SCHEMBL7682829

SCHEMBL7682829

CCOC(=O)/C=C(/N)c1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.50
ELANE P08246 1/20 0.44
MAPT P10636 3/20 0.43
GAA P10253 2/20 0.43
TRPV1 Q8NER1 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 4/20 0.42
TP53 P04637 1/20 0.41
HPGD P15428 4/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
POLB P06746 1/20 0.41
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31749890 1.00 PARP1 (0.50) PARP1ELANEMAPTGAATRPV1
SCHEMBL7682832 1.00 PARP1 (0.50) PARP1ELANEMAPTGAATRPV1
SCHEMBL7685587 0.89 PARP1 (0.47) PARP1ELANEMAPTGAASMN1; SMN2
SCHEMBL7685591 0.89 PARP1 (0.47) PARP1ELANEMAPTGAASMN1; SMN2
SCHEMBL11393110 0.85 PARP1 (0.53) PARP1ELANEMAPTHPGDALDH1A1
SCHEMBL11393086 0.85 PARP1 (0.53) PARP1ELANEMAPTHPGDALDH1A1
SCHEMBL30189436 0.84 PARP1 (0.51) PARP1MAPTGAASMN1; SMN2KMT2A
SCHEMBL12596917 0.84 LMNA (0.45) PARP1ELANEMAPTGAATRPV1
SCHEMBL20028184 0.83 LMNA (0.51) PARP1ELANEMAPTSMN1; SMN2KMT2A
SCHEMBL28665696 0.82 SMN1; SMN2 (0.49) MAPTGAASMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376521-B1 ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2002-04-23 US disclosed
WO-2000002861-A1 A3 ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-01-20 WO disclosed